Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
复制标题
DOI:
10.1084/jem.20040213
复制
发表时间:
2004-08-02
期刊:
影响因子:
--
通讯作者:
Mollinedo F
中科院分区:
文献类型:
--
作者:
Gajate C;Del Canto-Jañez E;Acuña AU;Amat-Guerri F;Geijo E;Santos-Beneit AM;Veldman RJ;Mollinedo F
We have discovered a new and specific cell-killing mechanism mediated by the selective uptake of the antitumor drug 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3, Edelfosine) into lipid rafts of tumor cells, followed by its coaggregation with Fas death receptor (also known as APO-1 or CD95) and recruitment of apoptotic molecules into Fas-enriched rafts. Drug sensitivity was dependent on drug uptake and Fas expression, regardless of the presence of other major death receptors, such as tumor necrosis factor (TNF) receptor 1 or TNF-related apoptosis-inducing ligand R2/DR5 in the target cell. Drug microinjection experiments in Fas-deficient and Fas-transfected cells unable to incorporate exogenous ET-18-OCH3 demonstrated that Fas was intracellularly activated. Partial deletion of the Fas intracellular domain prevented apoptosis. Unlike normal lymphocytes, leukemic T cells incorporated ET-18-OCH3 into rafts coaggregating with Fas and underwent apoptosis. Fas-associated death domain protein, procaspase-8, procaspase-10, c-Jun amino-terminal kinase, and Bid were recruited into rafts, linking Fas and mitochondrial signaling routes. Clustering of rafts was necessary but not sufficient for ET-18-OCH3–mediated cell death, with Fas being required as the apoptosis trigger. ET-18-OCH3–mediated apoptosis did not require sphingomyelinase activation. Normal cells, including human and rat hepatocytes, did not incorporate ET-18-OCH3 and were spared. This mechanism represents the first selective activation of Fas in tumor cells. Our data set a framework for the development of more targeted therapies leading to intracellular Fas activation and recruitment of downstream signaling molecules into Fas-enriched rafts.
登录
查看更多内容
影响因子:
32.4
作者:
Legler, DF;Micheau, O;Bron, C
通讯作者:
Bron, C
影响因子:
7.7
作者:
Hueber, AO;Bernard, AM;He, HT
通讯作者:
He, HT
影响因子:
3.6
作者:
Gajate, C;Santos-Beneit, A;Mollinedo, F
通讯作者:
Mollinedo, F
影响因子:
20.3
作者:
Cuvillier, O;Mayhew, E;Spiegel, S
通讯作者:
Spiegel, S
影响因子:
20.3
作者:
Gajate, C;Mollinedo, F
通讯作者:
Mollinedo, F